Lobbyist Public Search Mass. state house
Records prior to registration year 2005 are not available online.

Contact the Lobbyist Division here for assistance.
Search data is collected from registration records and disclosure reports submitted by lobbyists, lobbying entities, and their clients. Massachusetts General Law requires any party providing or retaining lobbying services to register annually, and submit disclosure reports twice a year.
Your comments are welcome:  submit feedback
Disclosure reporting details
Back to search detail summary
Lobbyist Entity disclosure reporting period:   07/01/2016 - 12/31/2016
Authorizing Officer name John F Heffernan
Title Principal
Business name Park Street Strategies, LLC
Address 30 Rowes Wharf    Suite, 600
City, state, zip code Boston , MA 02110         
Country US
Phone 617-981-0015 
 
Compensation/Salaries Paid
Lobbyist or Entity nameSalaries
John F Heffernan $0.00
Total salaries paid $0.00
 
Operating Expenses
DateRecipientType of expenseAmount
7/1/2016-12/31/2016 Advertising expenses $0.00
7/1/2016-12/31/2016 Photocopies, scans $0.00
7/1/2016-12/31/2016 Apple Northshore Computer equipment, supplies $1,963.50
7/1/2016-12/31/2016 Professional dues $0.00
7/1/2016-12/31/2016 Fax charges $0.00
7/1/2016-12/31/2016 McDermott Ventures Internet fees $180.00
7/1/2016-12/31/2016 Riley Dever, PC Legal fees $670.00
7/1/2016-12/31/2016 Postage, shipping, delivery $0.00
7/1/2016-12/31/2016 Office supplies, equipment $0.00
7/1/2016-12/31/2016 Printing expenses $0.00
7/1/2016-12/31/2016 Public relations expenses $0.00
7/1/2016-12/31/2016 McDermott Ventures Rent $13,500.00
7/1/2016-12/31/2016 Office and support staff salaries $0.00
7/1/2016-12/31/2016 Professional subscriptions $0.00
7/1/2016-12/31/2016 Taxes $0.00
7/1/2016-12/31/2016 AT&T Wireless Telephone, cell phone, handheld $1,293.37
7/1/2016-12/31/2016 Utilities (heat, water, electricity) $0.00
7/1/2016-12/31/2016 Other operating expenses $0.00
  Total operating expenses $17,606.87
 
Activities, Bill Numbers and Titles
Entity: Park Street Strategies, LLC
Client: kaléo
Total amount paid by client; lobbyist is unable to report compensation at activity level: $5,333.33
House / SenateBill Number or Agency NameBill title or activityAgent positionAmountDirect business association
Senate Bill 2010 An Act to improve the accessibility and affordability of naloxone and other pharmaceutical drugs of public health concern Neutral $0.00 n/a
House Bill 4201 An Act making appropriations for the fiscal year 2017 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements Neutral $0.00 n/a
House Bill 4450 An Act making appropriations for the fiscal year 2017 for the maintenance of the departments, boards, commissions, institutions and certain activities of the commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements Neutral $0.00 N/A
House Bill 4056 An Act relative to substance use, treatment, education and prevention Neutral $0.00 N/A
House Bill 4200 An Act making appropriations for the fiscal year 2017 for the maintenance of the departments, boards, commissions, institutions and certain activities of the Commonwealth, for interest, sinking fund and serial bond requirements and for certain permanent improvements Neutral $0.00 n/a
Senate Bill 2008 Report of the Special Senate Committee on Opioid Addiction Prevention, Treatment and Recovery Options Neutral $0.00 N/A
House Bill 2 An Act making appropriations for the fiscal year 2017 for the maintenance of the departments, boards, commissions, institutions, and certain activities of the commonwealth, for interest, sinking fund, and serial bond requirements, and for certain permanent improvements. Neutral $0.00 N/A
House Bill 3947 an act relative to substance use, treatment, education and prevention Neutral $0.00 N/A
Senate Bill 4 FY17 Senate Ways and Means Budget recommendations Neutral $0.00 n/a
House Bill 3926 special procedures for consideration of the House bill relative to substance use, treatment, education and prevention Neutral $0.00 N/A
    Total amount $0.00  
Entity: Park Street Strategies, LLC
Client: UCB, Inc.
Total amount paid by client; lobbyist is unable to report compensation at activity level: $21,000.00
House / SenateBill Number or Agency NameBill title or activityAgent positionAmountDirect business association
Senate Bill 1048 An Act to promote transparency and cost control of pharmaceutical drug prices Oppose $0.00 N/A
House Bill 1935 An Act Relative to Electronic Prescribing of Opiates and Other Controlled Substances Neutral $0.00 n/a
Senate Bill 519 An act relative to ensuring transparency of health plans formularies Support $0.00 n/a
Senate Bill 541 An Act Concerning out-of-pocket expenses for prescription drug coverage Support $0.00 N/A
    Total amount $0.00  
Entity: Park Street Strategies, LLC
Client: Shire
Total amount paid by client; lobbyist is unable to report compensation at activity level: $30,000.00
House / SenateBill Number or Agency NameBill title or activityAgent positionAmountDirect business association
Senate Bill 1048 An Act to promote transparency and cost control of pharmaceutical drug prices Oppose $0.00 N/A
Senate Bill 2103 An act relative to substance use, treatment, education and prevention (Conf. Comm.) Neutral $0.00 N/A
House Bill 4056 An Act Relative to Substance Use, Treatment, Education and Prevention Neutral $0.00 N/A
House Bill 1935 An Act Relative to Electronic Prescribing of Opiates and Other Controlled Substances Neutral $0.00 n/a
House Bill 2709 An Act designating the last day in February as Rare Disease Day in the Commonwealth Support $0.00 n/a
    Total amount $0.00  
Entity: Park Street Strategies, LLC
Client: Massachusetts Biotechnology Council
Total amount paid by client; lobbyist is unable to report compensation at activity level: $60,000.00
House / SenateBill Number or Agency NameBill title or activityAgent positionAmountDirect business association
Senate Bill 2313 An Act Relative to the Dispensing of Certain Cancer Related Drugs Support $0.00 N/A
Senate Bill 1042 An Act relative to responsible stewardship by drug manufacturers Oppose $0.00 n/a
House Bill 4434 An Act relative to the judicial enforcement of noncompetition agreements Neutral $0.00 n/a
House Bill 3465 An Act relative to patient access Support $0.00 n/a
House Bill 1761 An Act Relative to the Prohibition of Non-competition Agreements Oppose $0.00 n/a
Senate Bill 2305 Senate Final FY2017 Budget Recommendations (engrossed) Neutral $0.00 N/A
Senate Bill 1031 An act to improve medication adherence Support $0.00 n/a
House Bill 4432 An Act to relative to job creation, workforce development and infrastructure investment Neutral $0.00 n/a
House Bill 3270 An Act Establishing a Right to Try Neutral $0.00 n/a
House Bill 1719 An Act Relative to the Prohibition of Non-competition Agreements Oppose $0.00 n/a
Senate Bill 2010 An Act to improve the accessibility and affordability of naloxone and other pharmaceutical drugs of public health concern Neutral $0.00 n/a
Senate Bill 625 An act relative to patient access Neutral $0.00 n/a
House Bill 4201 House Final FY 2017 Budget (engrossed) Neutral $0.00 n/a
House Bill 2072 An Act ensuring a representative health care cost containment discussion Neutral $0.00 n/a
House Bill 828 An Act Relative to patient financial protection Neutral $0.00 n/a
Senate Bill 1188 An Act to reduce health care costs by promoting evidence-based prescriber education Oppose $0.00 n/a
Senate Bill 579 An act to establish Medicare for all in Massachusetts Oppose $0.00 n/a
House Bill 3983 An Act to provide opportunities for all Neutral $0.00 n/a
House Bill 1945 An Act promoting research and protecting public safety and environment Oppose $0.00 n/a
Senate Bill 1048 An Act to promote transparency and cost control of pharmaceutical drug prices Oppose $0.00 N/A
Senate Bill 1187 An Act to prevent undue influence on prescriber behavior Oppose $0.00 n/a
Senate Bill 563 An act to increase health insurer reporting transparency Support $0.00 n/a
House Bill 2 FY 17 Budget - Gov Neutral $0.00 n/a
House Bill 1935 An Act Relative to Electronic Prescribing of Opiates and Other Controlled Substances Neutral $0.00 n/a
Executive Chapter 441, An Act regulating pharmacy audits Support $0.00 N/A
Senate Bill 1165 An Act Relative to the Dispensing of Certain Cancer Related Drugs Support $0.00 n/a
Senate Bill 178 An Act protecting Massachusetts businesses from abusive patent infringement claims Oppose $0.00 n/a
House Bill 3926 An Act Relative to Substance Use, Treatment, Education and Prevention Neutral $0.00 n/a
House Bill 1908 An Act relative to prescription recycling Neutral $0.00 n/a
Senate Bill 4 SWM FY 2017 Budget Recommendations Neutral $0.00 N/A
Senate Bill 1002 An Act to Enhance Employment Opportunities Support $0.00 n/a
House Bill 4413 An Act to relative to job creation, workforce development and infrastructure investment Neutral $0.00 n/a
House Bill 3242 An Act establishing the Genetic Engineering Transparency Food and Seed Labeling Act Oppose $0.00 n/a
House Bill 1701 An act relative to the judicial enforcement of non-compete agreements Oppose $0.00 n/a
Senate Bill 1233 An Act establishing and financing a drug collection and disposal program Oppose $0.00 n/a
Senate Bill 581 An act to ensure access to medications Neutral $0.00 n/a
House Bill 4056 An Act Relative to Substance Use, Treatment, Education and Prevention Neutral $0.00 n/a
House Bill 1977 An Act to Create a Massachusetts Rare Disease Advisory Council Neutral $0.00 n/a
House Bill 791 An Act Relative to Patient Medication Adherence Support $0.00 n/a
Senate Bill 1524 An Act closing a corporate tax haven loophole Neutral $0.00 n/a
Senate Bill 607 An Act relative to Health Policy Commission oversight of insurer transactions Support $0.00 n/a
House Bill 4200 HWM FY 2017 Budget Neutral $0.00 n/a
House Bill 2059 An act to establishing a statewide discount program for pharmaceuticals Oppose $0.00 n/a
House Bill 792 An act relative to ensuring transparency of health plans formularies Support $0.00 n/a
Executive M.G.L. c.176O, §25 - Development of Standard Prior Authorization Forms Neutral $0.00 N/A
Senate Bill 1158 An Act relative to liability for genetically engineered food Oppose $0.00 n/a
Senate Bill 169 An Act to protect trade secrets and eliminate non-compete agreements Oppose $0.00 n/a
House Bill 3817 An Act Relative to Substance Use Treatment Neutral $0.00 n/a
House Bill 1894 An Act relative to retail pharmacy discounts and co-pay assistance. Support $0.00 n/a
Senate Bill 2103 An act relative to substance use, treatment, education and prevention (Conf. Comm.) Neutral $0.00 n/a
Senate Bill 957 An act relative to the judicial enforcement of non-compete agreements Oppose $0.00 n/a
House Bill 4323 An Act relative to the judicial enforcement of noncompetition agreements Neutral $0.00 n/a
House Bill 2709 An Act designating the last day in February as Rare Disease Day in the Commonwealth Support $0.00 n/a
House Bill 976 An Act further regulating the substitution of interchangeable biosimilars Support $0.00 n/a
Senate Bill 1508 An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing Oppose $0.00 n/a
Senate Bill 605 An Act to define modest meals and refreshments in prescriber education settings Oppose $0.00 n/a
House Bill 4156 An Act establishing the genetic engineering transparency food labeling act Oppose $0.00 n/a
House Bill 2013 An act to improve health planning & public health Neutral $0.00 n/a
House Bill 792 An act relative to ensuring transparency of health plans formularies Support $0.00 n/a
Senate Bill 2020 An Act relative to substance use prevention Neutral $0.00 n/a
Senate Bill 639 An act relative to mandatory prescription drug coverage Oppose $0.00 n/a
House Bill 4272 An Act relative to protecting health care consumers Neutral $0.00 n/a
House Bill 2477 An Act closing a certain corporate tax haven loophole Neutral $0.00 n/a
House Bill 870 An act to ensure access to generic medications Neutral $0.00 n/a
Executive Ch. 52, Acts of 2016, An Act Relative to Substance Use, Treatment, Education and Prevention Neutral $0.00 n/a
Senate Bill 1177 An Act to reduce healthcare costs by promoting non-biased prescriber education Oppose $0.00 n/a
Senate Bill 519 An act relative to ensuring transparency of health plans formularies Support $0.00 n/a
House Bill 3944 An Act Relative to Substance Use, Treatment, Education and Prevention Neutral $0.00 n/a
House Bill 1922 An Act relative to tests of newborn children for treatable disorders or diseases Support $0.00 n/a
Executive Ch. 224, Acts of 2012, An Act Improving the Quality of Health Care and Reducing Costs Through Increased Transparency, Efficiency, and Innovation Neutral $0.00 N/A
Senate Bill 1045 An act preventing prescription drug abuse by closing the pharmacy shopping loophole Neutral $0.00 n/a
House Bill 4450 FY2017 Budget Conference Committee Report Neutral $0.00 n/a
House Bill 3678 An Act relative to protecting health care consumers Neutral $0.00 n/a
House Bill 1807 An act relative to HPC oversight of insurer transactions Support $0.00 n/a
Executive 105 CMR 700.000 Implementation of MGL c. 94C, Controlled Substances Act Neutral $0.00 n/a
Senate Bill 1186 An Act to restore integrity in the marketing of pharmaceutical products and medical devices Oppose $0.00 n/a
Senate Bill 541 An Act Concerning out-of-pocket expenses for prescription drug coverage Support $0.00 An Act Concerning out-of-pocket expenses for prescription drug coverage
House Bill 3947 An Act Relative to Substance Use, Treatment, Education and Prevention Neutral $0.00 n/a
House Bill 1925 An act establishing provisions for the return of expired pharmaceuticals Oppose $0.00 n/a
    Total amount $0.00  
Entity: Park Street Strategies, LLC
Client: Biotechnology Innovation Organization (BIO)
Total amount paid by client; lobbyist is unable to report compensation at activity level: $20,000.00
House / SenateBill Number or Agency NameBill title or activityAgent positionAmountDirect business association
House Bill 1807 An act relative to HPC oversight of insurer transactions Support $0.00 N/A
Senate Bill 519 An act relative to ensuring transparency of health plans formularies Support $0.00 n/a
Senate Bill 639 An act relative to mandatory prescription drug coverage Oppose $0.00 n/a
House Bill 1807 An act relative to HPC oversight of insurer transactions Support $0.00 N/A
Senate Bill 541 An Act Concerning out-of-pocket expenses for prescription drug coverage Support $0.00 n/a
Senate Bill 605 An Act to define modest meals and refreshments in prescriber education settings Oppose $0.00 n/a
House Bill 1945 An Act promoting research and protecting public safety and environment Oppose $0.00 n/a
Executive Chapter 441, An Act regulating pharmacy audits Support $0.00 n/a
Senate Bill 1048 An Act to promote transparency and cost control of pharmaceutical drug prices Oppose $0.00 N/A
House Bill 3465 An Act relative to patient access Support $0.00 n/a
Senate Bill 1177 An Act to reduce healthcare costs by promoting non-biased prescriber education Oppose $0.00 n/a
House Bill 791 An Act Relative to Patient Medication Adherence Support $0.00 n/a
House Bill 2 FY 17 Budget - Gov Neutral $0.00 n/a
Senate Bill 1158 An Act relative to liability for genetically engineered food Oppose $0.00 n/a
House Bill 870 An act to ensure access to generic medications Neutral $0.00 N/A
House Bill 4201 House Final FY 2017 Budget (engrossed) Neutral $0.00 n/a
Senate Bill 1177 An Act to reduce healthcare costs by promoting non-biased prescriber education Oppose $0.00 n/a
House Bill 1894 An Act relative to retail pharmacy discounts and co-pay assistance. Support $0.00 n/a
Senate Bill 563 An act to increase health insurer reporting transparency Neutral $0.00 n/a
Senate Bill 581 An act to ensure access to medications Neutral $0.00 n/a
House Bill 3270 An Act Establishing a Right to Try Neutral $0.00 n/a
Senate Bill 2017 SWM FY 2017 Budget Recommendations Neutral $0.00 n/a
House Bill 2059 An act to establishing a statewide discount program for pharmaceuticals Oppose $0.00 n/a
Executive Ch. 224, Acts of 2012, An Act Improving the Quality of Health Care and Reducing Costs Through Increased Transparency, Efficiency, and Innovation Neutral $0.00 n/a
House Bill 976 An Act further regulating the substitution of interchangeable biosimilars Support $0.00 N/A
Senate Bill 169 An Act to protect trade secrets and eliminate non-compete agreements Oppose $0.00 n/a
Senate Bill 1042 An Act relative to responsible stewardship by drug manufacturers Oppose $0.00 n/a
House Bill 1908 An Act relative to prescription recycling Neutral $0.00 n/a
Executive 105 CMR 700.000 Implementation of MGL c. 94C, Controlled Substances Act Neutral $0.00 n/a
Senate Bill 579 An act to establish Medicare for all in Massachusetts Oppose $0.00 n/a
House Bill 3242 An Act establishing the Genetic Engineering Transparency Food and Seed Labeling Act Oppose $0.00 n/a
Senate Bill 2305 Senate Final FY2017 Budget Recommendations (engrossed) Neutral $0.00 n/a
House Bill 1925 An act establishing provisions for the return of expired pharmaceuticals Oppose $0.00 n/a
Executive Ch. 52, Acts of 2016, An Act Relative to Substance Use, Treatment, Education and Prevention Neutral $0.00 n/a
Senate Bill 563 An act to increase health insurer reporting transparency Support $0.00 n/a
House Bill 828 An Act Relative to patient financial protection Neutral $0.00 N/A
House Bill 4200 HWM FY 2017 Budget Neutral $0.00 n/a
Senate Bill 1186 An Act to restore integrity in the marketing of pharmaceutical products and medical devices Oppose $0.00 n/a
House Bill 1701 An act relative to the judicial enforcement of non-compete agreements Oppose $0.00 N/A
Senate Bill 178 An Act protecting Massachusetts businesses from abusive patent infringement claims Neutral $0.00 n/a
Senate Bill 1031 An act to improve medication adherence Support $0.00 n/a
House Bill 792 An act relative to ensuring transparency of health plans formularies Support $0.00 n/a
House Bill 4156 An Act establishing the genetic engineering transparency food labeling act Oppose $0.00 n/a
Senate Bill 1233 An Act establishing and financing a drug collection and disposal program Oppose $0.00 n/a
    Total amount $0.00  
 
Meals, Travel, and Entertainment Expenses
DateLobbyist nameEvent typeEvent locationNames and addresses of all event participantsAmount
07/18/2016Park Street Strategies, LLC Travel parking Boston Common Garage John Heffernan, 30 Rowes Wharf, Boston MA; Katie Joyce, 1 Shire Way. Lexington MA $28.00
08/04/2016Park Street Strategies, LLC Meal Jerry Remy's Restaurant John Heffernan, 30 Rowes wharf, Boston MA, Robert Coughlin, 300 Technology Sq., Cambridge. MA $89.90
09/19/2016Park Street Strategies, LLC Travel PI Alley Parking John Heffernan,30 Rowes wharf, Boston MA, John Prestidge, 3000 Hanover Street, Palo alto, CA, Charles Desourdy, 1 Ashburton Place, Boston MA $38.00
09/21/2016Park Street Strategies, LLC Travel LAZ Parking Boston MA John Heffernan, 30 Rowes Wharf, Boston MA, William Cass, 24 School Street, Boston MA $40.00
10/13/2016Park Street Strategies, LLC Travel Uber to 300 Technology Sq. John Heffernan, 30 Rowes wharf, Boston MA, Robert Coughlin, 300 Technology Sq., Cambridge. MA $10.71
10/20/2016Park Street Strategies, LLC Travel parking - PI Alley Garage Matt Harutunian, 1950 Lake Park Drive, Smyrna GA;William McDermott, 30 rowes Wharf, Boston MA, John Heffernan, 30 rowes Wharf, Boston MA $30.00
10/31/2016Park Street Strategies, LLC Travel Technology Sq. Parking Robert Coughlin, 300 Technology Sq., Cambridge, MA; John Heffernan, 30 Rowes Wharf, Boston MA $25.00
11/01/2016Park Street Strategies, LLC Travel Boston parking John Heffernan, 30 Rowes wharf, Boston MA, Robert Coughlin, 300 Technology Sq., Cambridge. MA; Raymond Campbell, 500 Boylston St., Boston, MA; Pat Cerundolo, 155 Seaport Blvd. Boston MA $2.65
11/10/2016Park Street Strategies, LLC Travel MB TA Parking and fare John Heffernan, 30 Rowes wharf, Boston MA, Robert Coughlin, 300 Technology Sq., Cambridge. MA $7.25
12/12/2016Park Street Strategies, LLC Travel technology Sq parking Ronald Mariano, State House Boston, MA; John Heffernan, 30 Rowes wharf, Boston MA, Robert Coughlin, 300 Technology Sq., Cambridge. MA $25.00
12/12/2016Park Street Strategies, LLC Travel technology Sq parking Stanley Rosenberg, State House Boston, MA; John Heffernan, 30 Rowes wharf, Boston MA, Robert Coughlin, 300 Technology Sq., Cambridge. MA $25.00
12/13/2016Park Street Strategies, LLC Travel Parking Boston Common John Heffernan30 Rowes Wharf, Boston MA, Michael Day, State House Boston MA,Matt Harutunian, 1950 Lake Park Drive, Smyrna GA $28.00
12/21/2016Park Street Strategies, LLC Travel Boston parking John Heffernan, 30 Rowes Wharf, Boston MA; Joseph Boncore, State House Boston, MA; Anthony Gesualdi, Sate House, Boston MA $2.65
    Total amount $352.16
 
Additional Expenses
No additional expenses were filed for this disclosure reporting period.
 
Campaign Contributions
DateLobbyist nameRecipient nameOffice soughtAmount
07/12/2016John F Heffernan Michael Moran Representative - 18th Suffolk $200.00
07/14/2016John F Heffernan Michael Rodrigues Senator - 1st Bristol and Plymouth $200.00
08/24/2016John F Heffernan Walter Timilty Senator - Norfolk, Bristol, Plymouth $200.00
09/21/2016John F Heffernan Aaron Michlewitz Representative - 3rd Suffolk $200.00
10/04/2016John F Heffernan Charlie Baker Governor $200.00
10/20/2016John F Heffernan Julian Cyr Senator - Cape and Islands $100.00
12/12/2016John F Heffernan Stanley Rosenberg Senator - Hampshire, Franklin, Worcester $200.00
   Total contributions $1,300.00
Close this page